Preprotachykinin-A mRNA expression in the human and monkey brain: An in situ hybridization study

Journal of Comparative Neurology

Volumn 411, Issue 1, 1999, Pages 56-72

  Hurd, Yasmin L ^a   Keller, Eva ^b   Sotonyi, Peter ^b   Sedvall, Göran ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Hippocampus; Islands of Calleja; Primate; Striatum; Substance P; Substantia innominata

Indexed keywords

PREPROTACHYKININ;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HYPOTHALAMUS; IN SITU HYBRIDIZATION; MONKEY; NONHUMAN; PEDUNCULAR ANSA; PERIAQUEDUCTAL GRAY MATTER; PRIMATE; PRIORITY JOURNAL; RNA ANALYSIS; STRIA TERMINALIS; SUBSTANTIA NIGRA;

ADULT; ANIMALS; BRAIN; CEREBELLUM; FEMALE; GENE EXPRESSION; HUMANS; IN SITU HYBRIDIZATION; LIMBIC SYSTEM; MACACA FASCICULARIS; MALE; MESENCEPHALON; MIDDLE AGED; NERVE TISSUE PROTEINS; ORGAN SPECIFICITY; PROSENCEPHALON; PROTEIN PRECURSORS; RNA, MESSENGER; SPECIES SPECIFICITY; SUBSTANCE P; TACHYKININS;

EID: 0033575751     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9861(19990816)411:1<56::AID-CNE5>3.0.CO;2-3     Document Type: Article

References (79)

1. Aggleton JP. 1992. The amygdala: neurobiological aspects of emotion, memory, and mental dysfunction. New York: Wiley-Liss, Inc.
2. Bannon MJ, Poosch MS, Haverstick DM, Mandal A, Xue IC-H, Shibata K, Dragovic LJ. 1992. Preprotachykinin gene expression in the human basal ganglia: characterization of mRNAs and pre-mRNAs produced by alternate RNA splicing. Mol Brain Res 12:225-231.
3. Beach TG, McGeer EG. 1984. The distribution of substance P in the primate basal ganglia: an immunohistochemical study of baboon and human brain. Neuroscience 13:29-52.
4. Beal MF, Schwartz KJ, Finn SF, Bird ED, Martin JB. 1988. Amino acid and neuropeptide neurotransmitters in Huntington's disease cerebellum. Brain Res 454:393-396.
5. Bogerts B. 1981. A brainstem atlas of catecholaminergic neurons in man, using melanin as a natural marker. J Comp Neurol 197:63-80.
6. Bouras C, Taban CH, Constantinidis J. 1984. Mapping of enkephalin in human brain. An immunofluorescence study on brains from patients with senile and presenile dementia. Neuroscience 12:179-190.
7. Bouras C, Vallet PG, Dobrinov H, de St-Hilaire S, Constantinidis J. 1986. Substance P neuronal cell bodies in the human brain: complete mapping by immunohistofluorescence. Neurosci Lett 69:31-36.
8. Bouras C, Vallet PG, Hof PR, Charnay Y, Golaz J, Constantinidis J. 1990. Substance P immunoreactivity in Alzheimer's disease: a study in cases presenting symmetric or asymmetric cortical atrophy. Alzheimer Dis Assoc Dis 4:24-34.
9. Bouthenet M-L, Souil E, Martres M-P, Sokoloff P, Giros B, Schwartz J-C. 1991. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res 564:203-219.
10. Brené S, Lindefors N, Kopp J, Hall H, Taubes T, Ehrlich M, Sedvall G, Greengard P, Persson H. 1994. Expression of mRNAs encoding ARPP-16/ 19, ARPP-21 and DARPP-32 in human brain tissue. J. Neurosci 14:985-998.
11. Canteras NS, Swanson LW. 1992. The dorsal premammillary nucleus: an unusual component of the mammillary body. Proc Natl Acad Sci USA 89:10089-10093.
12. Carpenter MB, Peter P. 1972. Nigrostriatal and nigrothalamic fibers in the rhesus monkey. J Comp Neurol 144:93-116.
13. Carter MS, Krause JE. 1990. Structure, expression, and some regulatory mechanisms of the rat preprotachykinin gene encoding substance P, neurokinin A, neuropeptide K, and neuropeptide τ. J Neurosci 10:2203-2214.
14. Chawla MK, Gutierrez GM, Young WS, Mcmullen NT, Rance NE. 1997. Localization of neurons expressing substance P and neurokinin B gene transcripts in the human hypothalamus and basal forebrain. J Comp Neurol 384:429-442.
15. Chergui K, Nomikos GG, Mathe JM, Gonon F, Svensson TH. 1996. Burst stimulation of the medial forebrain bundle selectively increase Fos-like immunoreactivity in the limbic forebrain of the rat. Neuroscience 72:141-56.
16. Chesselet M-F, Affolter H-U. 1987. Preprotachykinin messenger RNA detected by in situ hybridization in striatal neurons of the human brain. Brain Res 410:83-88.
17. Chesselet M-F, Bobbins E. 1989. Regional differences in substance P-like immunoreactivity in the striatum correlate with levels of preprotachykinin mRNA. Neurosci Lett 96:47-53.
18. Cornish JL, van den Buuse M. 1996. Regional expression of c-fos in rat brain following stimulation of the ventral tegmental area. Neurosci Lett 220:17-20.
19. Dahlström A, Fuxe K. 1964. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta. Physiol Scand 232(Suppl):1-55.
20. DeArmond SJ, Fusco MM, Dewey MM. 1989. A photographic atlas: structure of the human brain. New York: Oxford University Press.
21. de Lanerolle CN, Brines M, Williamson A, Kim HJ, Spencer DD. 1992. Neurotransmitters and their receptors in human temporal lobe epilepsy. In: Ribak CE, Gall CM, Mody I, editors. The dentate gyrus and its role in seizures. Amsterdam: Elsevier. p 235-250.
22. Del Fiacco M, Dessi ML, Levanti MC. 1984. Topographical localization of substance P in the human post-mortem brainstem. An immunohistochemical study in the newborn and adult tissue. Neuroscience 12:591-611.
23. Del Fiacco M, Levanti MC, Dessi ML, Zucca G. 1987. The human hippocampal formation and parahippocampal gyrus: localization of substance P-like immunoreactivity in newborn and adult post-mortem tissue. Neuroscience 21:141-150.
24. Del Fiacco M, Perra MT, Quartu M, Rosa MD, Zucca G, Levanti MC. 1988. Evidence for the presence of substance P-like immunoreactivity in the human cerebellum. Brain Res 446:173-177.
25. Diaz J, Lévesque D, Lammers CH, Griffon N, Martres M-P, Schwartz J-C, Sokoloff P. 1995. Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain. Neuroscience 65:731-745.
26. Duvernoy H. 1991. The human brain: surface, three-dimensional sectional anatomy and MRI. Wien: Springer Verlag.
27. Emson PC, Arregui A, Clement-Jones V, Sandberg BEB, Rossor M. 1980. Regional distribution of methionine-enkephalin and substance P-like immunoreactivity in normal human brain and in Huntington's disease. Brain Res 199:147-160.
28. Fallon JH, Loughlin SE, Ribak CE. 1983. The islands of Calleja complex of rat basal forebrain. III. Histochemical evidence for a striatopallidal system. J Comp Neurol 218:91-120.
29. Fernandez A, de Cabeallos ML, Jenner P, Marsden CD. 1992. Striatal neuropeptide levels in Parkinson's disease patients. Neurosci Lett 145:171-174.
30. Ferrante RJ, Kowall NW, Richardson EP Jr., Bird ED, Martin JB. 1986. Topography of enkephalin, substance P and acetylcholinesterase staining in Huntington's disease striatum. Neurosci Lett 71:283-288.
31. Goto S, Hirano A, Rojas-Corona RR. 1989. Immunohistochemical visualization of afferent nerve terminals in human globus pallidus and its alteration in neostriatal neurodegenerative disorders. Acta Neuropathol 78:543-550.
32. Grafe MR, Forno LS, Eng LF. 1985. Immunocytochemical studies of substance P and met-enkephalin in the basal ganglia and substantia nigra in Huntington's, Parkinson's and Alzheimer's diseases. J Neuropathol Exp Neurol 44:47-59.
33. Guo N, Klitenick MA, Tham CS, Fibiger HC. 1995. Receptor mechanisms mediating clozapine-induced c-fos expression in the forebrain. Neuroscience 65:747-756.
34. Haber SN, Watson SJ. 1985. The comparative distribution of enkephalin, dynorphin and substance P in the human globus pallidus and basal forebrain. Neuroscience 14:1011-1024.
35. Hall H, Halldin C, Sedvall G. 1993. Binding of [3H]SCH 39166 to human post mortem brain tissue. Pharmacol Toxicol 72:152-158.
36. Harlan R, Shivers B, Romano G, Howell R, Pfaff D. 1987. Localization of preproenkephalin mRNA in the rat brain and spinal cord by in situ hybridization. J Comp Neurol 258:159-184.
37. Harlan RE, Garcia MM, Krause JE. 1989. Cellular localization of substance P-and neurokinin A-encoding preprotachykinin mRNA in the female rat brain. J Comp Neurol 287:179-212.
38. Hurd YL. 1996. Differential messenger RNA expression of prodynorphin and proenkephalin in the human brain. Neuroscience 72:767-783.
39. Hurd YL, Herkenham M. 1993. Molecular alterations in the neostriatum of human cocaine addicts. Synapse 13:357-369.
40. Hurd YL, Herkenham M. 1995. Neuropeptide compartmentalization within the human neostriatum: in situ hybridization and in vitro autoradiography characterization. Neuroscience 64:571-586.
41. Hurley MJ, Stubbs CM, Jenner P, Marsden CD. 1996. Dopamine D3 receptors are not involved in the induction of c-fos mRNA by neuroleptic drugs: comparison of the dopamine D3 receptor antagonist GR103691 with typical and atypical neuroleptics. Eur J Pharmacol 318:283-293.
42. Inagaki S, Sakanaka M, Shiosaka S, Senba E, Takagi H, Takatsuki K, Kawai Y, Matsuzaki T, Iida J, Hara Y, Tohyama M. 1982. Experimental and immunohistochemical studies on the cerebellar substance P of the rat: localization, postnatal ontogeny and ways of entry to the cerebellum. Neuroscience 7:639-645.
43. Iritani S, Fujii M, Satoh K. 1989. The distribution of substance P in the cerebral cortex and hippocampal formation: an immunohistochemical study in the monkey and rat. Brain Res Bull 22:295-303.
44. Koob GF. 1992. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol 13:177-184.
45. Kosofsky BE, Genova LM, Hyman SE. 1995. Substance P phenotype defines specificity of c-fos induction by cocaine in developing rat striatum. J Comp Neurol 351:41-50.
46. Kowall NW, Quigley BJJ, Krause JE, Lu F, Kosofsky BE, Ferrante RJ. 1993. Substance P and substance P receptor histochemistry in human neurodegenerative diseases. Regul Peptides 46:174-185.
47. Krause JE, Chirgwin JM, Carter MS, Xu ZS, Hershey AD. 1987. Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. Proc Natl Acad Sci USA 84:881-885.
48. Landwehrmeyer B, Mengod G, Palacios JM. 1993. Dopamine D3 receptor mRNA and binding sites in human brain. Mol Brain Res 18:187-192.
49. Le Moine C, Bloch B. 1996. Expression of the D3 dopamine receptor in peptidergic neurons of the nucleus accumbens: comparison with the D1 and D2 dopamine receptors. Neuroscience 73:131-143.
50. MacGibbon GA, Lawlor PA, Bravo R, Dragunow M. 1994. Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. Mol Brain Res 23:21-32.
51. Maggio JE. 1988. Tachykinins.Annu Rev Neurosci 11:13-28.
52. Mai JK, Stephens PH, Hopf A, Cuello AC. 1986. Substance P in the human brain. Neuroscience 17:709-739.
53. Marshall PE, Landis DMD, Zalneraitis EL. 1983. Immunocytochemical studies of substance P and leucine-enkephalin in Huntington's disease. Brain Res 289:11-26.
54. Mauborgne A, Javoy-Agid F, Legrand JC, Agid Y, Cessetin F. 1983. Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains. Brain Res 268:167-170.
55. Meyer DJ, Frenk M. 1988. The role of neuropeptides in pain. In: Nemeroff CD, editor. Neuropeptides in psychiatric and neurological disorders. Baltimore: The Johns Hopkins University Press, p 199-280.
56. Moratalla R, Vickers EA, Robertson HA, Cochran BH, Graybiel AM. 1993. Coordinate expression of c-fos and jun B is induced in the rat striatum by cocaine. J Neurosci 13:423-433.
57. Nisbet AP, Foster OJF, Kingsbury A, Eve DJ, Daniel SE, Marsden CD, Lees AJ. 1995. Preproenkephalin and preprotachykinin messenger RNA expression in normal human basal ganglia and in Parkinson's disease. Neuroscience 66:361-376.
58. Nomura H, Shiosaka S, Tohyama M. 1987. Distribution of substance P-like immunoreactive structures in the brainstem of the adult human brain: an immunocytochemical study. Brain Res 404:365-370.
59. Papez JW. 1937. A proposed mechanism of emotion. Arch Neurol 38:725-743.
60. Parent A. 1996. Carpenter's human neuroanatomy. Baltimore: Williams and Wilkins.
61. Paxinos G. 1990. The human nervous system. New York: Academic Press, Inc.
62. Pernow B. 1983. Substance P. Pharmacol Rev 35:85-141.
63. Pioro EP, Mai JK, Cuello AC. 1990. Distribution of substance P- and enkephalin immunoreactive neurons and fibers. In: Paxinos G, editor. The human nervous system. New York: Academic Press, Inc. p 1051-1094.
64. Quigley BJJ, Kowall NW. 1991. Substance P-like immunoreactive neurons are depleted in Alzheimer's disease cerebral cortex. Neuroscience 41:41-60.
65. Reiner A, Albin RL, Anderson KD, D'Amato CJ, Penney JB, Young AB. 1988. Differential loss of striatal projection neurons in Huntington's disease. Proc Natl Acad Sci USA 85:5733-5737.
66. Richfield EK, Maguire-Zeiss KA, Vonkeman HE, Voorn P. 1995. Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients. Ann Neurol 38:852-861.
67. Ronnekleiv OK, Kelly MJ, Eskay RL. 1984. Distribution of immunoreactive substance P neurons in the hypothalamus and pituitary of the rhesus monkey. J Comp Neurol 224:51-59.
68. Sakamoto N, Michel J-P, Kopp N, Tohyama M, Pearson J. 1987. Substance P- and enkephalin-immunoreactive neurons in the hippocampus and related areas of the human infant brain. Neuroscience 22:801-811.
69. Sakamoto S, Goto S, Ito J, Hirano A. 1992. Striosomal organization of substance P-like immunoreactivity in parkinsonian patients. Neurology 42:1071-1075.
70. Sapp E, Ge P, Aizawa H, Bird E, Penney J, Young AB, Vonsattel JP, DiFiglia M. 1995. Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis. Neuroscience 64:397-404.
71. Seress L, Leranth C. 1996. Distribution of substance P-immunoreactive neurons and fibers in the monkey hippocampal formation. Neuroscience 71:633-650.
72. Shibata H. 1987. Ascending projections to the mammillary nuclei in the rat: a study using retrograde and anterograde transport of wheat germ agglutinin conjugated to horseradish peroxidase. J Comp Neurol 264: 205-221.
73. Sloviter RS. 1987. Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy. Science 73-76.
74. Sloviter RS. 1994. On the relationship between neuropathology and pathophysiology in the epileptic hippocampus of humans and experimental animals. Hippocampus 4:250-253.
75. Stephan H, Schwerdtfeger WK, Baron G. 1980. The brain of the common marmoset (Callitrix jacchus). Berlin: Springer-Verlag.
76. Sukhov RR, Walker LC, Rance NE, Price DL, Young WS III. 1995. Opioid precursor gene expression in the human hypothalamus. J Comp Neurol 353:604-622.
77. Suzuki M, Hurd YL, Sokoloff P, Schwartz J-C, Sedvall G. 1998. Anatomical distribution of D3 dopamine receptor mRNA in the human brain. Brain Res 779:58-74.
78. Terenius L, Wahlström A, Lindström LK, Widerlöv E. 1976. Increased CSF levels of endorphins in chronic psychosis. Neurosci Lett 3:157-162.
79. Warden MK, Young WS III. 1988. Distribution of cells containing mRNAs encoding substance P and neurokinin B in the rat central nervous system. J Comp Neurol 272:90-113.